NCT04393389 - Acotec DCB Post Market Clinical Follow-up | Biotech Hunter

Enrollment

3,000

Participants

Timeline

Start Date

June 4, 2020

Primary Completion Date

December 1, 2025

Study Completion Date

March 1, 2027

Conditions

Peripheral Artery Disease

Interventions

DEVICE

"AcoArt Orchid (0.035), AcoArt Tulip (0.018) and AcoArt Litos (0.014) percutaneous transluminal angioplasty (PTA) paclitaxel drug coated balloon catheter manufactured by Acotec Scientific Co., Ltd."

All comers Post Market Clinical Follow-up to continue the surveillance of the Acotec Drug Coated PTA Catheter AcoArt Orchid, AcoArt Tulip and AcoArt Litos in lower limb treatment

Trial Locations (7)

Unknown

RECRUITING

Halle, Halle

RECRUITING

Eilenburg, Eilenburg

RECRUITING

Department of Angiology, University Hospital Leipzig,, Leipzig

RECRUITING

Elblandklinikum Radebeul, Radebeul

RECRUITING

Elblandklinikum Radebeul, Riesa

RECRUITING

REGIOMED Klinikum Sonneberg, Sonneberg

RECRUITING

KKH Torgau, Torgau